Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.13 +0.12 (+2.99%)
At close: Oct 1, 2026 · 4:00 PM EDT

Adial Pharmaceuticals (ADIL) Cash from Financing Activities (2017 - 2026)

Updated

Adial Pharmaceuticals (ADIL) reported Cash from Financing Activities of $25.21 million for Q2 2026, up 375.8% from $5.3 million a year earlier.

Analysis

Adial Pharmaceuticals (ADIL) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Adial Pharmaceuticals' Cash from Financing Activities came in at $28.65 million, up 219.8% year-over-year; for FY2025, it came in at $8.47 million, up 8.0% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 8.6% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $7.85 million in FY2024 (+89.9%), $4.13 million in FY2023 (-54.7%), $9.13 million in FY2022 (-33.1%) and $13.64 million in FY2021 (+143.3%).
  • The Q2 2026 figure ranks as the highest quarterly Cash from Financing Activities in data going back to Q3 2017.
  • Year over year, Cash from Financing Activities gained in two of the last four quarters, with growth averaging 178.5%.
  • The high point for year-over-year Cash from Financing Activities in five years was Q1 2024 (growth of 527.3%); the low point was Q2 2022 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $315,284 (Q1 2026), $2.6 million (Q4 2025) and $524,801 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Adial Pharmaceuticals 18.53 Mn 18.53 Mn - 25.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.21 Mn
Mar 31, 2026 315,284.00
Dec 31, 2025 2.60 Mn
Sep 30, 2025 524,801.00
Jun 30, 2025 5.30 Mn
Mar 31, 2025 50,648.00
Sep 30, 2024 3.61 Mn
Jun 30, 2024 411,091.00
Mar 31, 2024 3.82 Mn
Dec 31, 2023 3.38 Mn
Sep 30, 2023 138,669.00
Jun 30, 2023 58.00
Mar 31, 2023 609,613.00
Jun 30, 2022 1,865.00
Mar 31, 2022 9.12 Mn
Dec 31, 2021 1.25 Mn
Sep 30, 2021 5.50 Mn
Jun 30, 2021 2.81 Mn
Mar 31, 2021 4.08 Mn
Sep 30, 2020 950,008.00
API Access

Adial Pharmaceuticals Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ADIL&period=max&api_key=YOUR_API_KEY